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Self-reported lactose intolerance in clinic patients with functional gastrointestinal 
symptoms: prevalence, risk factors and impact on food choices 
ABSTRACT 
Background: Many patients complain of abdominal symptoms with dairy products; however, 
clinical and psychosocial factors associated with self-reported lactose intolerance (SLI) have 
not been assessed in large studies. In particular, data is lacking from lactase deficient 
populations. This prospective cohort study assessed the prevalence of, and risk factors for, 
SLI in Chinese patients attending a gastroenterology clinic.  
Methods: Consecutive patients completed questionnaires to assess digestive health (Rome 
III), psychological state (HADS), life event stress (LES), food intake and quality-of-life 
(SF-8). A representative sample completed genetic studies and hydrogen breath testing (HBT) 
at the clinically relevant dose of 20g lactose. 
Key Results: SLI was present in 410/910 (45%) clinic patients with functional abdominal 
symptoms. The genotype in all subjects was C/C-13910. A small number of novel SNPs in 
lactase promoter region were identified, including C/T-13908 which appeared to confer 
lactase persistence. Over half of the patients (54%) completed the 20g lactose HBT with 58% 
(285/492) reporting typical symptoms. Positive and negative predictive values of SLI for 
abdominal symptoms during HBT were 60% and 44%, respectively. Psychological state and 
stress were not associated with SLI in clinic patients. SLI impacted on physical quality-of-life 
and was associated with reduced ingestion of dairy products, legumes and dried fruit 
(p≤0.05).  
Conclusions & Inferences: In a lactase deficient population, approximately half of patients 
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attending clinic with functional gastrointestinal symptoms reported intolerance to dairy 
products; however, SLI did not predict findings on 20g lactose HBT. Independent of 
psychosocial factors, SLI impacted on quality-of-life and impacted on food choices with 
restrictions not limited to diary products. 
 
Key Messages: 
• In a lactase deficient population, approximately half of patients attending clinic with 
functional gastrointestinal symptoms reported intolerance to dairy products. 
• SLI did not predict the occurrence of symptoms by 20g Lactose HBT. 
• SLI subjects avoided lactose intake from dairy products and reduced intake also of other 
foods, such as legumes and dried fruit, known to cause bloating and flatulence.  
• Independent of psychosocial factors, the presence of food intolerance impacted on 
quality-of-life. 
 
Key Words: FODMAPs; hydrogen breath test; lactase deficiency; lactose intolerance; 
psychological state. 
 
Abbreviations：HBT, hydrogen breath test; HADS, hospital anxiety and depression scale; 
LM, lactose malabsorption; LI, lactose intolerance; LEST, life event stress test; SLI, 
self-reported lactose intolerance; SNP, single nucleotide polymorphism; TSS, total symptom 
score. 
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INTRODUCTION 
Lactose is the major carbohydrate found in milk and dairy products and is used widely by the 
food industry in processed foods. Lactase deficiency leads to lactose malabsorption (LM) 
with passage of undigested nutrient into the colon.1, 2 Lactose intolerance (LI) refers to 
digestive symptoms such as bloating, diarrhea and abdominal pain that occur as a result of the 
production of gas and other products of bacterial fermentation in the digestive tract.  
The presence of lactase deficiency on genetic sequencing or lactose malabsorption on 
hydrogen breath tests (HBT) does not automatically mean that patients report clinically 
relevant symptoms after ingestion of lactose at the level found in the normal diet.3, 4 Indeed, 
9 in 10 individuals with lactase deficiency tolerate a cup of milk (10g lactose) and 1 in 5 can 
take up to a liter of milk (40g lactose) without reporting symptoms.5-7 Conversely others, 
often those with functional gastrointestinal symptoms (e.g. dyspepsia, irritable bowel 
syndrome), claim that ingestion of dairy products causes symptoms when there is no evidence 
of lactose malabsorption.7, 8 On this basis, controlled tests of food tolerance at clinically 
relevant doses have been recommended to ensure that any advice to restrict dairy products is 
based on objective rather than subjective evidence.9 
Recently we have identified demographic, psycho-social and clinical risk factors for 
food intolerance at clinically relevant doses (20g lactose HBT) in a Chinese population with 
primary lactase deficiency: an in-vivo model of food intolerance in humans.5, 10 Extrinsic 
factors related to lactose intolerance included lactose dose, small intestinal bacterial 
overgrowth and high levels of H2 production from the colonic microbiota. Patient factors 
such as anxiety, stress and the presence of functional gastrointestinal disease were also 
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associated with food intolerance.5, 10, 11 
The association between self-reported lactose intolerance (SLI) and objective evidence 
of lactose malabsorption intolerance on HBT at any dose was weak.5 This is important 
because individuals with SLI may limit intake of dairy products and may avoid other 
products thought to cause abdominal symptoms.12 The presence of multiple food intolerances 
can impact on quality of life.13 Multiple dietary exclusions can lead to a highly restrictive diet 
deficient in vital micronutrients. For example, self-imposed reductions in consumption of 
dairy products have been linked to reduced calcium intake, increased bone turnover and, 
ultimately, an increased risk of osteoporosis and fracture.14, 15 SLI has also been associated 
with other conditions such as diabetes and hypertension,16 although it remains uncertain 
whether the latter associations are related to reduced intake of dairy products or whether this 
is a non-specific consequence of lifestyle and food choices. 
These concerns highlight the need to identify patients with self-reported food intolerance 
that are making inappropriate food choices that could impact on nutritional health and quality 
of life. This prospective cohort study aimed to determine the prevalence and risk factors for 
SLI in a large group of adult patients attending a gastroenterology clinic. The association 
between objective and self-reported assessment of lactose malabsorption and intolerance was 
assessed. The impact of SLI on quality of life and food choices was documented.  
 
METHODS 
Subjects and study design 
The present study was conducted in Sir Run Run Shaw Hospital in Hangzhou in the 
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South-Eastern China. Consecutive patients aged 16-74 with lower digestive tract symptoms 
without alarm symptoms (i.e. dysphagia, anaemia, overt blood loss, abdominal mass and 
weight loss) attending the morning gastrointestinal clinic were included and completed a 
series of questionnaires via face-to-face interview to assess the prevalence of functional 
gastrointestinal disease as defined by the Rome III criteria, psychosocial status, nutritional 
intake and quality of life (see next section). As is typical in the Chinese health system, more 
than 90% of patients attending hospital clinics were self-referrals (i.e. hospitals provide a 
primary care service). 
Participants with a past history of organic gastrointestinal disease (e.g. peptic ulcer, 
inflammatory bowel disease), diabetes mellitus, thyroid disease, drug abuse and alcohol 
addiction were excluded. Individuals with a history of abdominal surgery except 
appendectomy, cholecystectomy and hernia repair were also excluded. All participants signed 
a written informed consent form and the study was approved by the ethical committee of Sir 
Run Run Shaw Hospital and registered (ClinicalTrials.gov: NCT01286597). Studies were 
conducted in accordance with the Declaration of Helsinki and written informed consent was 
obtained from all participants.  
 
Questionnaires 
All questionnaires were completed under supervision of investigators to ensure participants 
understood questions and responded to all questions. 
1. SF-8: Short version of the SF-36 questionnaire documenting quality of life in 8 
domains: physical functioning, role-physical, bodily pain, general health, vitality, social 
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functioning, role-emotional and mental health. Higher scores indicate a better health-related 
quality of life. 
    2. FBD: Rome III questionnaire to diagnose functional gastrointestinal disease.  
    3. HADS (Hospital anxiety and depression scale): HADS score ≥ 11 was taken as 
clinically significant level of anxiety or depression, with a cut-off score ≥ 8 for diagnosing 
borderline neurosis. For the purposes of categorical analysis anxiety or depression was 
defined as a score of ≥ 8 for each respective scale in our study. 
4. LEST (Life Event Stress Test): The social readjustment rating scale measuring 
stressful events in life.17 Culturally specific items (e.g. currency) were translated. A sum score 
was computed using the weights given in the cited publication. 
5. FFQ: Food intake frequency and portion sizes was recorded using a standardized 
questionnaire validated in a Chinese population18. This FFQ is a list of 30 foods, including 
dairy products: milk, yoghurt, flavored milk, milk-powder, condensed milk. Non-dairy foods 
included bread, cake, biscuit, sausage, chocolate, ice-cream and cheese. Daily lactose intake 
from milk products was recorded separately from lactose in other food sources and the total 
amount of lactose calculated by reference to the USDA National Nutrient Database 
(http://www.nal.usda.gov/fnic/foodcomp/search/, accessed on October 4, 2012).  
6. Self-reported Lactose Intolerance (SLI) was present in an individual if he or she 
responded “yes” to the question “Do you have abdominal discomfort such as abdominal pain, 
bloating, diarrhea after intake of milk or dairy products?” People who responded “no” or 
“don’t know” were classified as not having SLI. 
7. General information: Demographic data of subjects (age, gender, marital status, 
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education, profession, income range), smoking and alcohol consumption, past medical and 
surgical history. 
 
Lactose hydrogen breath test  
Patients that attended gastroenterology clinic in the morning completed a 20g lactose 
hydrogen breath test (HBT, equivalent to 400ml milk) validated for use in populations with a 
high rate of lactase deﬁciency.5, 11 This was not feasible for patients attending in the afternoon 
due to the 3 hours duration of the test. Exhaled hydrogen was recorded every 15 min for 3 h 
by a portable analyzer. LM was diagnosed if peak H2 breath excretion exceeded ≥20ppm 
over the baseline value on at least 2 consecutive readings. The number and the severity of 
individual symptoms (nausea, bloating, abdominal pain, borborygmi and diarrhea) during and 
after the test within 24h were assessed by a Likert scale (0=absence, 1=trivial, 2=mild, 
3=moderate, 4=strong, 5=severe symptoms). The total symptom score (TSS) was calculated 
as the sum of the highest intensity value for each symptom.19 LI was diagnosed if, in the 
presence of LM, a greater than 1 point rise in TSS was reported on at least two consecutive 
measurements.5, 10 
 
Genetic sequencing of lactase gene regulatory sequence (genotype) 
A large sample of clinic patients completed genetic testing for primary lactase deficiency (i.e. 
sequencing of lactase gene regulatory sequence). Reference data from healthy volunteers was 
on file. White cells were isolated from a whole blood sample using a modified salting-out 
procedure, and DNA was extracted (Axygen, Union City, CA, USA). A 446-bp region within 
Zheng   9 
 
intron 13 of MCM6 (13807bp to 14253bp upstream of the lactase gene) was amplified by 35 
PCR cycles (forward primer (5'-CGGATGCACTGCTGTGATGA-3'), reverse primer 
(5'-ACTGACCTATCCTCGTGGAATG-3')). Single Nucleotide Polymorphisms (SNPs) 
associated with lactase persistence in European (C/T-13910), African and Arabian 
(C/G-13907, T/G-13915, G/C-14010) populations were identified by bi-directional 
sequencing using Sequencher software (vs. 4.0.5, GeneCodes).20, 21 
Statistical analysis 
The appropriate number of participants to recruit was estimated based on published data from 
the South Chinese population that reported (i) ~80% and ~90% prevalence of lactose 
malabsorption at 20g and 40g lactose respectively, in both healthy controls and IBS patients5,  
(ii) approximately 50% prevalence in gastroenterology clinics (data on file, Sir Run Run 
Shaw Hospital). Based on this data, if lactose intolerance is self-reported by half of IBS 
patients, then inclusion of 600 hospital patients (after correction for co-morbidity) 
provides >80% power of detecting an increase in IBS symptoms associated with dietary 
lactose compared to controls at a risk ratio of 2:1 (p<0.05). For the mechanistic lactose breath 
tests performed in the hospital population, and assuming 40% placebo response (typical in 
functional bowel disease),22 this study design has a 80% power to detect a 20% difference in 
prevalence of lactose intolerance following 20g lactose challenge between groups.  
All statistical analyses were performed using the Statistical Package for Social Sciences 
for Windows (SPSS16.0 for Windows). Student’s t-test was used to compare means and 
Mann-Whitney U test was used for non-parametric statistical test. Qualitative data 
comparisons used the chi-square test. Mixed model analysis was used to compare lactose 
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consumption from diary and non-dairy foods. All variables were expressed as mean±s.d. or 
median with quartiles as appropriate. Alpha <0.05 was considered significant.  
 
RESULTS 
A total of 1022 patients with lower digestive tract symptoms without alarm symptoms 
attending gastrointestinal clinic of Sir Run Run Shaw hospital were recruited during the study 
period. 112 patients were excluded due to the presence of organic disease or incomplete 
questionnaire responses. Thus, results from 910 (89.0%) outpatient patients were analyzed.  
 
Study participant characteristics and prevalence of SLI 
The prevalence of SLI in clinic patients was 45.2% (411/910). The prevalence of IBS in SLI 
subjects was significantly higher than in non-SLI subjects (61.3% (252/411) vs. 47.3% 
(236/499), p<0.001). The socio-demographic characteristics of subjects with and without SLI 
are detailed in Table 1. Patients with SLI were younger, had a higher educational level and a 
higher family income level than those without SLI (p<0.05). 
 
Psychiatric state, Life Events Stress and quality of life 
In clinic patients, the level of anxiety and depression was high, with nearly 1 in 5 subjects 
reporting anxiety or depression. 32.6% SLI patients and 32.9% non-SLI subjects had 
psychological disease (Table 1). There was no difference in the prevalence of psychological 
disease or life event stress between the two groups (Table 2). Subjects with SLI had a lower 
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quality of life than those without SLI as assessed by SF-8 score (including total items and 
physical but not emotional items). (Table 3) 
 
Objective and self-reported markers of lactose intolerance 
Patients that attended gastroenterology clinic in the morning completed a 20g lactose 
HBT (492/910 (54%) of total) of whom 232 (47%) self reported lactose intolerance (SLI). 
Patient selection was determined by time of clinic attendance only and there was no 
difference in clinical or other characteristics between patients that completed HBT and those 
that did not (data on file).  
Lactose Malabsorption (definition in methods) was confirmed by an increase in breath 
hydrogen in 374 (76%) and abdominal symptoms of lactose intolerance were reported by 
285/492 (58%). Patients with irritable bowel syndrome defined by the Rome III criteria had 
the same rate of lactose malabsorption to other patients but tended to report lactose 
intolerance during HBT more frequently (61% (161/264) vs. 54% (124/228), p=0.14) (Figure 
1). With HBT taken as the diagnostic standard, the sensitivity, specificity, positive predictive 
value (PPV) and negative predictive value (NPV) of SLI was 48.8%, 55.1%, 59.9% and 
43.9%, respectively.  
A large sample of clinic patients (n=640) and reference data from healthy volunteers that 
had completed 20g HBT (n=82) underwent genetic sequencing of the lactase gene promoter 
region. The T-13910 allele was not detected in any individual. The genotype in all 
participants was C/C-13910 (Figure 2). Several novel SNPs were identified in the same 
region, including C/T-13908 (n=1), A/C-13926 (n=2) and G/A-14010 (n=2). Only the 
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C/T-13908 genotype appeared to confer lactase persistence with a negative 20g lactose HBT 
(no H2 production and no symptoms). No significant association was present.  
 
Intake of lactose from dairy and non-dairy source 
In hospital populations subjects that reported SLI ingested less lactose from dairy 
products than those without SLI (p=0.032); however lactose intake from non-dairy sources 
(i.e. commercially processed foods) was similar (Table 4).  
Intake of major food groups and also alcohol was similar in SLI and non-SLI subjects. 
Further, when foods containing poorly absorbed, fermentable carbohydrates and related 
substances (i.e. FODMAPs) were considered, patients with and without SLI reported broadly 
similar food choices on the FFQ (Table 5). In general, where differences existed between 
groups (e.g. Zucchini), the amounts eaten were small; however, subjects with SLI ate 
significantly less legumes (e.g. beans, lentils) and dried fruit compared to individuals that did 
not self-report food intolerance. 
 
DISCUSSION 
The prevalence of SLI was high (45%) in a large cohort of patients attending a 
gastroenterology clinic for investigation and treatment of functional digestive symptoms. 
Previous surveys documented self-reported lactose intolerance in 10-25% of the community 
and in 22-28% of patients with irritable bowel syndrome.2, 5, 23 Clearly higher rates of food 
intolerance in this study reflect the population studied, the setting in a gastrointestinal clinic 
and, very likely, increased intake of dairy products and awareness of lactose intolerance as a 
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cause of abdominal symptoms in China.24 
About half of clinic patients had SLI; however, the prevalence of primary lactase 
deficiency in the South Chinese population approaches 100%.5, 25 The discrepancy between 
the “genetic biomarker” and “self-reported clinical impact” of this condition can be explained 
by the interaction between the amount of lactose in the diet and individual sensitivity to the 
products of lactose fermentation.5, 10 In healthy individuals 70-80% report abdominal 
symptoms after ingestion of 40-50g lactose (equivalent to 1 liter of milk); however, 
symptoms are much less common at lower doses (3% at 10g and 22% at 20g lactose).5 The 
average daily intake of lactose by clinic patients in China was 2.0g with only 5.8% taking 
more than 10.0g per day. At these low levels even IBS patients rarely experience symptoms.5 
Nevertheless, some patients with SLI base their opinion on the occurrence of symptoms after 
taking a large quantity of milk drinks or ice cream on one particular occasion, and others may 
wrongly attribute symptoms to unfamiliar or unpalatable dairy products in the past. 
Genetic studies of primary lactase deficiency have identified a common 
single-nucleotide polymorphism (SNP) in the promoter region 13910 base pairs upstream 
from the structural gene coding for lactase on chromosome 2q.21-22.21 This polymorphism 
consists of the nucleotide switch of T for C, resulting in variants CC, CT or TT-13910. 
Enattah and other authors 26-30 have shown that CC-13910 is a good predictor for loss of 
intestinal lactase activity and a genetic test of C/T (-13910) polymorphism can be used as a 
first stage screening test for adult-type hypolactasia. We tested 640 clinic patients and 82 
healthy volunteers in the Chinese population. All had the C/C-13910 genotype. A small 
number of novel SNPs in the same region were identified; however only one individual with 
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genotype C/T-13908 (i.e. 2 base pairs from the common SNP) had lactase persistence on 
lactose HBT. This is a random SNP in a single individual and provides no evidence that the 
ability to digest lactose confers a selective advantage in the Chinese population. Certainly, 
consistent with other studies in non-European countries,31 gene testing of the C/T (-13910) 
polymorphism should not be used in screening for lactase persistence in this setting. The lack 
of genotype-phenotype association also confirms that genetic testing does not predict lactose 
intolerance at doses found in the normal diet. 
Factors associated with self-reported lactose intolerance to dairy products were identified 
from responses to questionnaires. SLI was not associated with anxiety, depression or life 
event stress in clinic patients in the present study. This is consistent with results reported by 
Bohn et al. from a clinical study in Europe,13 but contrasts with the results from a large 
population based study in the Hangzhou population (n=2000) that did show higher rates of 
SLI in individuals with psychiatric disease and / or high levels of stress (unpublished data). 
The explanation for this somewhat unexpected finding may be the generally high rates of both 
physical and psychiatric disease in clinic attendees.32 Prospective trials have shown that the 
presence of psychosocial problems and physical co-morbidity increase the risk of developing 
post-infectious IBS after an attack of food poisoning.33-35 The same factors also increase the 
risk of food intolerance during a blinded lactose hydrogen breath test (HBT).5, 10 This study 
adds “the patient’s perspective” to this physiological data. The similarity of food intolerance 
and IBS symptoms suggest that these conditions may well share a common 
pathophysiology.36 Experimental and clinical evidence have shown that intolerance to a range 
of poorly absorbed, fermentable carbohydrates (FODMAPs (i.e. Fermentable Oligo-, Di-, and 
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Mono-saccharides And Polyols (includes lactose in patients with lactase deficiency)) and 
indigestible fiber can be the cause of functional abdominal symptoms.37-39 Lactose, may be 
considered a “facultative” FODMAP, as the dose reaching the distal small bowel and colon 
depends on enzyme activity in the proximal small bowel. Physiological studies have shown 
that individuals affected by psychosocial problems and those with functional gastrointestinal 
disease are hypersensitive to visceral events including the gas production caused by lactose 
malabsorption.5, 10 The current study provides evidence that patients can also be 
“hypervigilant” to dietary factors that may cause digestive discomfort. 
    The impact of SLI on the diet was evident in clinic patients. Individuals with SLI 
consumed significantly less lactose in the form of milk, yoghurt, cream and ice cream than 
other subjects. However, this effect did not extend to a reduction in lactose intake from 
non-dairy products (e.g. biscuits, sausage and other commercially processed foods) in which 
lactose content may not be obvious. The impact of SLI on the intake of other foods was less 
consistent; however, reductions in legumes and dried fruit were noted. This is of interest 
because these items are well-known to cause bloating and flatulence. Thus, it appears that 
individuals with SLI restrict intake of food and drink known to cause abdominal symptoms, 
but not of other substances that also have high levels of fermentable, poorly absorbed 
carbohydrates but are less well-known to cause problems such as wheat and soft drinks 
containing fructose.36 
     The inconsistency of food choices provides further evidence that most people find it 
difficult to identify specific items that cause digestive symptoms. This was evident even for 
lactose intake in subjects with lactase deficiency (i) by the very weak positive predictive 
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value present between SLI and the occurrence of abdominal symptoms during 20g lactose 
HBT and, (ii) by the fact that only SLI and not lactose intolerance on HBT predicted reduced 
intake of dairy products. This may explain why IBS patients rarely succeed in controlling 
their condition by self-directed restriction of dairy products.40 Rather dietary advice and 
support provided by a dietician is required to reduce the foods that can trigger functional 
abdominal symptoms and to ensure that a health, balanced diet is maintained.39, 41-43 
The strengths of this study include the large, representative sample of subjects recruited 
in gastroenterology clinic with assessment of demographic, clinical, psychosocial and dietary 
information using validated questionnaires. Further, performance of the study in a Chinese 
population with 100% prevalence of lactase deficiency facilitated interpretation of the results 
since all subjects shared the same “genetic risk” of lactose malabsorption and intolerance. 
Conversely, the limitation of studying SLI in China is that the average intake of dairy 
products is lower than in Europe and the USA. This may impact on the generalizability of the 
findings; although, similar findings for SLI prevalence and its impact on dairy intake have 
been reported in Western populations.16, 23 
In conclusion, in a population with lactase deficiency, SLI was present almost 1 in 2 
patients attending clinic for investigation of functional digestive symptoms. SLI did not 
predict the occurrence of symptoms by 20g Lactose HBT and it was subjective perception of 
food intolerance and not objective malabsorption that influenced food choices. SLI subjects 
avoided lactose intake from dairy products and reduced intake also of foods, such as legumes 
and dried fruit, known to cause bloating and flatulence. Future studies are required to assess 
whether dietary restriction impacts on the general and nutritional health of these individuals. 
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Table 1 General demographic, social and medical characteristics of SLI and non-SLI 
subjects from gastroenterology clinic in Sir Run Run Shaw Hospital 
 
Variables Levels SLI (n=411) 
Non-SLI 
(n=499) p-value 
Age, yr Mean±SD 43.0±12.0  45.1±11.9  0.010  
Sex, n(%) Male 219(53.3%)   284(56.9%)   
Female 192(46.7%)   215(43.1%)  0.273  
Marital status, n(%) Married 361(87.8%)  439(88.0%)   
Single 37(9.0%)  35(7.0%)  0.227  
Unmarried 13(3.2%)  25(5.0%)   
Education, n(%) 
 
 
 
<=primary 81(19.7%)   153(30.7%)   
Middle school  100(24.3%)   158(31.7%)  <0.001  
High School 120(29.2%)   105(21.0%)   
>=college 110(26.8%)   83(16.6%)   
Average Family 
income RMB/month 
n(%) 
<1000 34(8.3%)  59(11.8%)   
1000~ 228(55.5%)  317(63.5%)  0.001  
5000~ 57(13.9%)  50(10.0%)   
>=10000 92(22.4%)  73(14.6%)   
Job, n(%) Office work  53(12.9%) 45(9.0%)  
Physical work  235(57.2%) 315(63.1%) 0.009 
Housework  104(25.3%) 131(26.3%)  
Student  19(4.6%) 8(1.6%)  
Cigarette Smoking,  
n(%) 
Never 306(74.5%)  346(69.3%)   
1~ 50(12.2%)   75(15.0%)  0.167  
10~ 23(5.6%)  23(4.6%)   
20~ 32(7.8%)   55(11.0%)   
Alcohol Drinking, 
n(%) 
Never  183(44.5%)  222(44.5%)   
Some time  173(42.1%)  170(34.1%)  0.005  
Often 43(10.5%)   90(18.0%)   
Always 12(2.9%)  17(3.4%)   
Medical History， 
n(%) 
No 218(53.0%)  261(52.3%)  0.825  
Yes 193(47.0%)  238(47.7%)   
 
Psychological 
Disease (HADS >8)  
 
No 
Yes 
 
277(67.4%) 
134 (32.6%) 
 
335(67.1%) 
164 (32.9%) 
 
0.933 
n(%)     
HADS, hospital anxiety and depression scale; SLI, self-reported lactose intolerance. 
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Table 2 Anxiety, Depression and Life Event Stress reported by SLI and non-SLI 
subjects from hospital groups 
 
 SLI (n=411) Non-SLI (n=499)  p-value 
Anxiety    
Yes 98 (23.8%) 98(19.6%) 0.125 
No 313(76.2%) 401(80.4%)  
Depression    
Yes 105(25.5%) 121 (24.2%) 0.652 
No 306(74.5%) 378 (75.8%)  
LEST 51.0 (16.0~105.0) 54.0 (16.0~104.0) 0.762 
SLI, self-reported lactose intolerance; LEST, life event stress test. 
 
Table 3 SF-8 scale score in SLI and non-SLI subjects from hospital 
 
SLI, self-reported lactose intolerance; PCS, average score from four physical items; 
MCS, average score from four mental items; TSF8, average score from eight items. 
 
Table 4 Lactose intake from dairy and non-dairy sources in SLI and non-SLI subjects. 
(g month-1)  
 
 SLI (n=411) Non-SLI (n=499) p-value 
Dairy 13 (0-59) 14 (0-62) 0.0318 
Non-dairy 24 (8-59) 18 (5-46) 0.1881 
SLI, self-reported lactose intolerance. 
 
 SLI (n=411) Non-SLI (n=499) p-value 
PCS 45.10±7.82 46.40±7.81 0.0035 
MCS 48.11 ±7.83 48.44±8.06 0.6499 
TSF8 46.50 ±5.08 47.25±4.97 0.0144 
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Table 5 Food intake of selected foods and beverages from FFQ in SLI and non-SLI 
subjects from hospital groups (kg month-1) 
 
 SLI (n=411) Non-SLI (n=499) p-value 
Apple 1.2(0.4-1.6) 1.2(0-1.2) 0.125 
Pear 0(0-0.8) 0(0-0.8) 0.247 
Mandarin 0(0-1.2) 0.4(0-1.2) 0.316 
Apricot 0(0-0) 0(0-0) 0.369 
Peaches 0(0-0) 0(0-0) 0.676 
Grapes 0(0-0.8) 0(0-0.4) 0.075 
Watermelon 0.8(0-1.2) 0.4(0-1.2) 0.658 
Dried fruit 0(0-0.4) 0(0-0.4) 0.052 
Carbonated 0(0-1.2) 0(0-1.6) 0.429 
Honey 0(0-0) 0(0-0) 0.527 
Wine 0(0-0) 0(0-0) 0.722 
Onion 0(0-0.4) 0(0-0.4) 0.117 
Cabbage 0.8(0.4-1.2) 0.8(0-1.2) 0.038 
Artichoke 0(0-0) 0(0-0) 0.505 
Zucchini 0(0-0.8) 0(0-0.4) 0.051 
Legumes 1.0(0.8-3.0) 1.2(0.8-3.0) 0.037 
Noodles 1.2(0.8-2.0) 1.2(0.8-2.4) 0.518 
Gum 0(0-0) 0(0-0) 0.464 
SLI, self-reported lactose intolerance. Values were expressed as median with 25th and 
75th quartiles. 
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Figure 1 
Relationship between subjective and objective lactose tolerance in study population 
 
